Page 128 - Read Online

Li et al. Mini-invasive Surg 2019;3:15 I http://dx.doi.org/10.20517/2574-1225.2018.13 Page 5 of 6

Financial support and sponsorship
None.

Conflicts of interest
Both authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2019.

REFERENCES
1. Dubecz A, Solymosi N, Stadlhuber RJ, Schweigert M, Stein HJ, et al. Does the incidence of adenocarcinoma of the esophagus and
gastric cardia continue to rise in the twenty-first century?-a SEER database analysis. J Gastrointest Surg 2013.
2. Zhou Y, Zhang Z, Zhang Z, Wu J, Ren D, et al. A rising trend of gastric cardia cancer in Gansu Province of China. Cancer Lett
2008;269:18-25.
3. Oezcelik A, DeMeester SR. General anatomy of the esophagus. Thorac Surg Clin 2011;21:289-97.
4. Odze RD. Pathology of the gastroesophageal junction. Semin Diagn Pathol 2005;22:256-65.
5. Wallner B. Endoscopically defined gastroesophageal junction coincides with the anatomical gastroesophageal junction. Surg Endosc
2009;23:2155-8.
6. Siewert JR, Holscher AH, Becker K, Gossner W. Cardia cancer: attempt at a therapeutically relevant classification. Chirurg 1987;58:25-
32.
7. Siewert JR, Stein HJ. Carcinoma of the gastroesophageal junction - classification, pathology and extent of resection. Dis Esophagus
1996;9:173-82.
8. Sasako M, Sano T, Yamamoto S, Sairenji M, Arai K, et al. Left thoracoabdominal approach versus abdominal-transhiatal approach for
gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol 2006;7:644-51.
9. Kurokawa Y, Sasako M, Sano T, Yoshikawa T, Iwasaki Y, et al. Ten-year follow-up results of a randomized clinical trial comparing left
thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or
gastric cardia. Br J Surg 2015;102:341-8.
10. Lewis I. The surgical treatment of carcinoma of the oesophagus; with special reference to a new operation for growths of the middle
third. Br J Surg 1946;34:18-31.
11. Omloo JM, Lagarde SM, Hulscher JB, Reitsma JB, Fockens P, et al. Extended transthoracic resection compared with limited transhiatal
resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 2007;246:992-
1000; discussion 1000-1.
12. Hulscher JB, van Sandick JW, de Boer AG, Wijnhoven BP, Tijssen JG, et al. Extended transthoracic resection compared with limited
transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347:1662-9.
13. Blank S, Schmidt T, Heger P, Strowitzki MJ, Sisic L, et al. Surgical strategies in true adenocarcinoma of the esophagogastric junction
(AEG II): thoracoabdominal or abdominal approach? Gastric Cancer 2018;21:303-14.
14. Haverkamp L, Seesing MF, Ruurda JP, Boone J, R VH. Worldwide trends in surgical techniques in the treatment of esophageal and
gastroesophageal junction cancer. Dis Esophagus 2017;30:1-7.
15. Mine S, Sano T, Hiki N, Yamada K, Kosuga T, et al. Proximal margin length with transhiatal gastrectomy for Siewert type II and III
adenocarcinomas of the oesophagogastric junction. Br J Surg 2013;100:1050-4.
16. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 2017;20:1-19.
17. Pedrazzani C, de Manzoni G, Marrelli D, Giacopuzzi S, Corso G, et al. Lymph node involvement in advanced gastroesophageal junction
adenocarcinoma. J Thorac Cardiovasc Surg 2007;134:378-85.
18. Siewert JR, Stein HJ, Feith M. Adenocarcinoma of the esophago-gastric junction. Scand J Surg 2006;95:260-9.
19. Nunobe S, Ohyama S, Sonoo H, Hiki N, Fukunaga T, et al. Benefit of mediastinal and para-aortic lymph-node dissection for advanced
gastric cancer with esophageal invasion. J Surg Oncol 2008;97:392-5.
20. Yamashita H, Seto Y, Sano T, Makuuchi H, Ando N, et al. Results of a nation-wide retrospective study of lymphadenectomy for
esophagogastric junction carcinoma. Gastric Cancer 2017;20:69-83.
21. Yoshikawa T, Takeuchi H, Hasegawa S, Nozaki I, Kishi K, et al. Theoretical therapeutic impact of lymph node dissection on
adenocarcinoma and squamous cell carcinoma of the esophagogastric junction. Gastric Cancer 2016;19:143-9.
22. Barreto JC, Posner MC. Transhiatal versus transthoracic esophagectomy for esophageal cancer. World J Gastroenterol 2010;16:3804-10.
23. Mariette C, Piessen G, Briez N, Gronnier C, Triboulet JP. Oesophagogastric junction adenocarcinoma: which therapeutic approach?
Lancet Oncol 2011;12:296-305.